Molecular Signatures of Hepatitis C Virus (HCV)-Induced Type II Mixed Cryoglobulinemia (MCII)
Open Access
Abstract
The role of hepatitis C virus (HCV) infection in the induction of type II mixed cryoglobulinemia (MCII) and the possible establishment of related lymphoproliferative disorders, such as B-cell non-Hodgkin lymphoma (B-NHL), is well ascertained. However, the molecular pathways involved and the factors predisposing to the development of these HCV-related extrahepatic complications deserve further consideration and clarification. To date, several host- and virus-related factors have been implicated in the progression to MCII, such as the virus-induced expansion of selected subsets of B-cell clones expressing discrete immunoglobulin variable (IgV) gene subfamilies, the involvement of complement factors and the specific role of some HCV proteins. In this review, we will analyze the host and viral factors taking part in the development of MCII in order to give a general outlook of the molecular mechanisms implicated.Keywords
This publication has 141 references indexed in Scilit:
- Chronic Hepatitis C Virus Infection Breaks Tolerance and Drives Polyclonal Expansion of Autoreactive B CellsClinical and Vaccine Immunology, 2012
- Identification of the Niemann-Pick C1–like 1 cholesterol absorption receptor as a new hepatitis C virus entry factorNature Medicine, 2012
- A flow cytometry-based strategy to identify and express IgM from VH1-69+ clonal peripheral B cellsJournal of Immunological Methods, 2010
- HLA DR-DQ combination associated with the increased risk of developing human HCV positive non-Hodgkin's lymphoma is related to the type II mixed cryoglobulinemiaTissue Antigens, 2010
- Characterization of Antibodies Directed against the Immunoglobulin Light κ Chain Variable Chain Region (VK) of Hepatitis C Virus‐Related Type‐II Mixed Cryoglobulinemia and B‐Cell ProliferationsAnnals of the New York Academy of Sciences, 2009
- The Tight Junction-Associated Protein Occludin Is Required for a Postbinding Step in Hepatitis C Virus Entry and InfectionJournal of Virology, 2009
- Differential neutralization efficiency of hemagglutinin epitopes, antibody interference, and the design of influenza vaccinesProceedings of the National Academy of Sciences, 2009
- Structural and functional bases for broad-spectrum neutralization of avian and human influenza A virusesNature Structural & Molecular Biology, 2009
- Human occludin is a hepatitis C virus entry factor required for infection of mouse cellsNature, 2009
- Claudin-1 is a hepatitis C virus co-receptor required for a late step in entryNature, 2007